MAGNETIC METAL OXIDE COATED POLYMER NANOPARTICLES AND USE THEREOF Russian patent published in 2013 - IPC A61K47/48 A61K47/30 A61K47/02 A61K38/19 A61P35/00 B82B3/00 B82Y5/00 

Abstract RU 2472530 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to nanoparticles for drug delivery with the nanoparticles consisting of a metal-chelating polymer, and an active agent representing a related TNF ligand inducing apoptosis (TRAIL) wherein the active agent is covalently bond with the polymer. The invention also refers to the pharmaceutical composition for inducing apoptosis in a cancer cell, reducing tumour growth and/or tumour growth inhibition which involves said nanoparticles and a pharmaceutically acceptable carrier. What is also declared is a method for preparing the nanoparticles which involves mixing the aqueous solution of the metal-chelating polymer with a soluble metal salt, oxidation of metal ions and formation of the nanoparticles by reducing pH to a basic level. Then the stages of metal addition, oxidation and reduction to basic pH are performed again. They are followed by nanoparticle functionalisation and contact with TRAIL, and blocking of the rest active sites on the surface of the nanoparticles.

EFFECT: invention provides reducing the effective apoptosis ensured by TRAIL stabilisation, prevented splitting and reduced TRAIL amount required for apoptosis.

27 cl, 30 dwg, 8 ex

Similar patents RU2472530C2

Title Year Author Number
HEMOPOIETIC CELL CD34+ AND USE THEREOF 2005
  • Dzhanni Alessandro M.
  • Karlo-Stella Karmelo
  • Kolotta Franchesko
RU2390558C2
ANTITUMOUR AGENT BASED ON BIODEGRADABLE NANOPARTICLES CARRYING A RECOMBINANT HUMAN TUMOR NECROSIS FACTOR ALPHA 2018
  • Danilenko Elena Dmitrievna
  • Levagina Galina Mikhajlovna
  • Volosnikova Ekaterina Aleksandrovna
  • Lebedev Leonid Rudolfovich
  • Sysoeva Galina Mikhajlovna
  • Vyazovaya Elena Alekseevna
RU2691938C1
METHOD OF TREATMENT OF TUMORS 2003
  • Denardo Salli Dzh.
  • Berk Patrisija A.
  • Denardo Dzherald L.
  • Gudman Sajmon
  • Mattsku Zigfrid
RU2323737C2
METHOD FOR INHIBITING CEREBRAL TUMORS GROWTH DUE TO SELECTED ANTAGONISTS OF INTEGRINS 2000
  • Log Uolter E.
RU2255765C2
MULTIFUNCTIONAL HYBRID RECOMBINANT PROTEIN MEDICINAL PRODUCTS FOR THE TREATMENT OF TUMOR DISEASES 2022
  • Gasparian Marine Eduardovna
  • Iagolovich Anna Valerevna
  • Artykov Artem Aleksandrovich
  • Isakova Alina Alekseevna
  • Dolgikh Dmitrii Aleksandrovich
  • Kirpichnikov Mikhail Petrovich
RU2801367C1
COMPOSITIONS AND METHODS FOR MALIGNANT NEOPLASMS PREVENTION AND TREATMENT 2011
  • Santamariya Pere
RU2623038C2
RECOMBINANT ALBUMEN WITH ANTI-CANCER EFFECT, GENE CODING IT, AND APPLICATION THEREOF 2003
  • Chzhu Bin
RU2333221C2
NANOPARTICLE BASED, TUMOUR-TARGETED DELIVERY OF MEDICINAL AGENTS 2011
  • Rejsfeld Ralf A.
  • Syan Zhun
  • Lo Yunpin
  • Lyao Debbi
  • Lyu Tsze
  • Chen Tinmej
  • Chen Sy
  • Lu Den
RU2593367C2
COMBINATION OF ANTIBODY HAVING SELECTIVITY IN RELATES TO APOPTOSIS INDUCING LIGAND RECEPTOR ASSOCIATED WITH TUMOR NECROSIS FACTOR AND OTHER THERAPEUTIC AGENTS 2002
  • Chzhou Tun
  • Itikava Kimikhisa
  • Kimberli Robert P.
  • Kupman Uil'Jam Dzh.
  • Osumi Dzhun
  • Lobuglio Al'Bert F.
  • Bukhsbaum Donal'D Dzh.
RU2313368C2
MODULAR PARTICLES FOR IMMUNOTHERAPY 2014
  • Fakhmi, Tarek
  • Khorsburg, Brajan
RU2672055C2

RU 2 472 530 C2

Authors

Mardzhel Shlomo

Perlshtejn Benni

Broudi Chaja

Mikkelsen Tom

Dates

2013-01-20Published

2008-09-24Filed